Karin posted it. It came via email. It might just be a Newsletter to shareholders but don’t know.
“Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.
Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.
The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.”
A man asked a boy if the swamp before him had a hard bottom. The boy said yes. But the traveller's horse sank in up to the girths. "I thought you said that this bog had a hard bottom." "So it has," said the boy, "but you have not got half way to it yet."